News | Published:

Scientists jailed for alleged theft from Harvard laboratory

Naturevolume 417page886 (2002) | Download Citation


San Diego

A married couple have been arrested and imprisoned in San Diego pending trial for their alleged theft of genetic material from Harvard University for shipment to an unnamed drug company in Japan.

Federal investigators say the couple stole genetic clones, reagents and records relating to immunosuppressive drug development from a Harvard molecular biology laboratory where they both worked in 1999.

Supporters of the pair in San Diego say that, although the couple made “stupid” mistakes at Harvard, they are being treated excessively harshly for doing what postdoctoral fellows often do.

The two researchers — Jiangyu “Jonathan” Zhu, a Chinese citizen, and his wife, Kayoko Kimbara, a citizen of Japan — or their attorneys could not be reached for comment on the case. The couple, who were arrested on 19 June, are seeking release on bail, but the US Attorney's office wants them to be detained and taken to Boston for trial.

After a two-year investigation by the Federal Bureau of Investigation (FBI), federal prosecutors issued a criminal complaint on 17 June, charging the pair with theft of trade secrets, interstate transportation of stolen property and conspiracy. These felony charges carry a maximum prison term of ten years and fines of up to $250,000 each.

Zhu's and Kimbara's arrest is at least the third case of Asian biologists working in the United States being jailed pending theft charges in the past year (see Nature 411, 225–226; 200110.1038/35077271 and Nature 417, 576; 200210.1038/417576b). But the cases were each handled by different law-enforcement agencies and so do not seem to be a part of an organized crackdown.

The couple met when they were postdocs in the Harvard Medical School laboratory of cell biologist Frank McKeon, who studies genetic control of the immune system. They allegedly stole materials and data relating to the genetic regulation of calcineurin, a signalling protein in the heart, brain and immune system.

An FBI affidavit claims that the pair switched to night shifts, worked without supervision and discovered potentially new immune-system genes, which were not disclosed to McKeon. After falling out with McKeon in 1999, the affidavit says that they moved in January 2000 to the University of Texas Health Science Center in San Antonio, where Zhu was made an assistant professor with Kimbara as his postdoc.

The pair removed more than 30 boxes of materials from McKeon's lab late at night, at the end of 1999, according to the affidavit. In early 2000, it claims, Harvard officials went to San Antonio, where they searched Zhu's lab, locating and repossessing Harvard material that they valued at $300,000. Texas officials then declined to renew Zhu's contract, prompting him and his wife to leave that summer.

Unable to secure a research position, Zhu contacted Jean Wang, a molecular biologist at the University of California, San Diego (UCSD), who says she decided to give him “a second chance” in January 2001.

While Zhu began a new line of research on apoptosis in thyroid cancer cells in Wang's laboratory, Kimbara took up a postdoctoral position at the Scripps Research Institute in La Jolla, working in the vascular-biology lab of Mark Ginsberg.

Wang, who consulted McKeon before hiring Zhu, feels that a double standard is being applied to the couple, as postdocs often take reagents and records when they leave a laboratory. “It is horrible,” says Wang of the prosecution. “It is like a goliath crushing an ant.”

Wang acknowledges, however, that she wasn't aware of the alleged transfer of research material to Japan until this May. After she learned of the FBI inquiry into a transfer, Wang says Zhu told her he sent plasmids to a former McKeon postdoc who had returned to his native Japan. This was described as an innocent scientific exchange to create antibodies, Wang recalls.

But federal records allege that e-mails show that the material was destined for commercial use for a possible drug to block organ rejection. The Japanese company — which has not been named — is cooperating with the US authorities and has returned the Harvard material.


  1. Search for Rex Dalton in:

About this article

Publication history

Issue Date


Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing